Literature DB >> 2883173

Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder.

E Othmer, S C Othmer.   

Abstract

After 4 weeks' treatment with buspirone, sexual function was normalized in 8 of 10 patients with generalized anxiety disorder. Nine of the patients had reported decreased sexual function before treatment. Buspirone appears to offer a clinical advantage over existing anxiolytics, which are usually associated with impairment of sexual function.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2883173

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


  7 in total

Review 1.  The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.

Authors:  Sheryl A Kingsberg; Anita H Clayton; James G Pfaus
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

2.  Major depressive disorder, obsessive-compulsive disorder, and generalized anxiety disorder: do the sexual dysfunctions differ?

Authors:  Arvind Kendurkar; Brinder Kaur
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

3.  Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor.

Authors:  Thomas L Schwartz; Umar A Siddiqui; Stephen M Stahl
Journal:  Ther Adv Psychopharmacol       Date:  2011-06

Review 4.  Prosexual drugs: empirical status of the "new aphrodisiacs".

Authors:  R C Rosen; A K Ashton
Journal:  Arch Sex Behav       Date:  1993-12

5.  Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use.

Authors:  Mandeep Singh; Thomas L Schwartz
Journal:  Neuropsychiatr Dis Treat       Date:  2012-03-23       Impact factor: 2.570

Review 6.  New developments in the treatment of hypoactive sexual desire disorder - a focus on Flibanserin.

Authors:  Christopher J Jayne; Michael J Heard; Sarah Zubair; Dustie L Johnson
Journal:  Int J Womens Health       Date:  2017-04-10

7.  A review of vilazodone, serotonin, and major depressive disorder.

Authors:  Kerri A Pierz; Michael E Thase
Journal:  Prim Care Companion CNS Disord       Date:  2014-01-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.